Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_provenance.
- befree-2016 importedOn "2016-02-19" NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_provenance.
- NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_assertion wasGeneratedBy ECO_0000203 NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_provenance.
- NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_assertion wasDerivedFrom befree-2016 NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_provenance.
- NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_assertion SIO_000772 17091508 NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_provenance.
- NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_assertion evidence source_evidence_literature NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_provenance.
- NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_assertion description "[Published FDA-validated HPV testing follow-up data show that the expected rates of CIN III+ and CIN II+ in the HPV-negative ASC-US population are 1.4% and 5%, respectively, with PPV/NPVs (CIN II+) of 20%/99%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578336.RAGEu0ikKZAjFSIA7trOUy-pmlaOxcMtpSe09QDVKkqpY130_provenance.